NewsScan
A Daily Summary of Healthcare and Business News
11/23/2021 - The Morgantown News
MORGANTOWN, WV - West Virginia University School of Public Health efforts to help track the spread of COVID-19 through contact tracing, mapping, wastewater monitoring and more played a pivotal role in West Virginia’s response to the pandemic, officials say.
A subscription may be necessary to view this article.
11/23/2021 - MetroNews by: Carrie Hodousek
HUNTINGTON, WV - Representatives with Cabell Huntington Hospital and SEIU District 1199 head back to court Tuesday over a temporary restraining order in connection with the ongoing maintenance and service worker strike.
A subscription may be necessary to view this article.
11/23/2021 - The Hill by: Monique Wilson
WASHINGTON, DC - Lawmakers are encouraging a reexamination of the health care industry to address social and economic factors to make it more accessible to the general public.
A subscription may be necessary to view this article.
11/23/2021 - WBOY
GRAFTON, WV - Congressman David McKinley has been taking tours of small, rural hospitals in the Mon Health System. On Monday, he stopped at Grafton City Hospital in Taylor County.
A subscription may be necessary to view this article.
11/23/2021 - WBOY
WESTON, WV - Two West Virginia healthcare systems specializing in drug addiction solutions are teaming up trying to reduce the overdose death rate.
A subscription may be necessary to view this article.
11/22/2021 - NPR by: Rhitu Chatterjee
WASHINGTON, DC - Even before the federal government's recent decision last week to authorize COVID boosters all adults, it had already recommended them in October for people with certain high-risk conditions.
A subscription may be necessary to view this article.
11/22/2021 - Kaiser Health News by: JoNel Aleccia
WASHINGTON, DC - Within a few weeks, perhaps before many Americans finish decorating for the holidays, the U.S. could have access to a new antiviral pill from Merck expected to alter the deadly trajectory of the covid-19 pandemic — with a second option from Pfizer to follow shortly after.
A subscription may be necessary to view this article.